Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

Cardiology groups speak up | Seeking answers after the FDA approved TAVR for asymptomatic AS | SDD after cardiac ablation

News You Need to Know Today
Cardiology groups speak up | Seeking answers after the FDA approved TAVR for asymptomatic AS | SDD after cardiac ablation
Thursday, May 15, 2025
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Editor's Choice: Policy & Regulations

Cardiology groups among the many voices asking Congress not to cut Medicaid

More than 40 U.S. healthcare organizations are urging Congress not to make sweeping Medicaid cuts that could result in approximately 7.6 million Americans losing health insurance.

READ MORE >
Kit Crancer, chair of the Radiology Business Management Association Radiology (RBMA) Patient Action Network, and senior vice president of public policy for Rayus, explains RBMA's concerns over how the Trump administration's $1 trillion in cuts to Medicaid will economically impact rural hospitals.
Share on Twitter Share on Facebook Share on Linkedin

Cardiology groups among the many voices asking Congress not to cut Medicaid

Share on Twitter Share on Facebook Share on Linkedin
Kit Crancer, chair of the Radiology Business Management Association Radiology (RBMA) Patient Action Network, and senior vice president of public policy for Rayus, explains RBMA's concerns over how the Trump administration's $1 trillion in cuts to Medicaid will economically impact rural hospitals.
More than 40 U.S. healthcare organizations are urging Congress not to make sweeping Medicaid cuts that could result in approximately 7.6 million Americans losing health insurance.
READ MORE >

ASNC, ACC ask US government not to tariff radiopharmaceuticals

The two groups stressed that tariffs would likely impact patient care.

READ MORE >
Cardiac SPECT nuclear imaging myocardial perfusion_Spectrum Dynamics_RSNA22_DF_3.jpeg
Share on Twitter Share on Facebook Share on Linkedin

ASNC, ACC ask US government not to tariff radiopharmaceuticals

Share on Twitter Share on Facebook Share on Linkedin
Cardiac SPECT nuclear imaging myocardial perfusion_Spectrum Dynamics_RSNA22_DF_3.jpeg
The two groups stressed that tariffs would likely impact patient care.
READ MORE >

Answering key follow-up questions after the FDA approved TAVR in asymptomatic patients

The approval of certain TAVR valves to be used in asymptomatic patients is expected to make a significant impact on patient care going forward. 

READ MORE >
A majority of medical devices involved in Class I recalls were never required by the U.S. Food and Drug Administration (FDA) to undergo premarket or postmarket clinical testing, according to new research published in Annals of Internal Medicine.[1]
Share on Twitter Share on Facebook Share on Linkedin

Answering key follow-up questions after the FDA approved TAVR in asymptomatic patients

Share on Twitter Share on Facebook Share on Linkedin
A majority of medical devices involved in Class I recalls were never required by the U.S. Food and Drug Administration (FDA) to undergo premarket or postmarket clinical testing, according to new research published in Annals of Internal Medicine.[1]
The approval of certain TAVR valves to be used in asymptomatic patients is expected to make a significant impact on patient care going forward. 
READ MORE >

Nonprofit group helps doctors and startups bring new cardiovascular tech to market

Nabil Dib, MD, founder of the International Society for Cardiovascular Translational Research, details resources to help doctors and startups navigate the shift from conducting research to commercializing new products and applications.

READ MORE >
Nabil Dib, MD, director clinical and translational research, Dignity Health, and founder of the non-profit International Society for Cardiovascular Translational Research (ISCTR), explains resources ISCTR has to help doctors and start ups navigate regulatory pathways to expedite moving from research to clinical application.
Share on Twitter Share on Facebook Share on Linkedin

Nonprofit group helps doctors and startups bring new cardiovascular tech to market

Share on Twitter Share on Facebook Share on Linkedin
Nabil Dib, MD, director clinical and translational research, Dignity Health, and founder of the non-profit International Society for Cardiovascular Translational Research (ISCTR), explains resources ISCTR has to help doctors and start ups navigate regulatory pathways to expedite moving from research to clinical application.
Nabil Dib, MD, founder of the International Society for Cardiovascular Translational Research, details resources to help doctors and startups navigate the shift from conducting research to commercializing new products and applications.
READ MORE >

Atrial Fibrillation Centers of Excellence: The best path forward for high-quality care and better outcomes

The world is in the throes of an AFib pandemic, one that could potentially get worse in the years ahead due to population growth, economic hardships and rigid resource limitations. According to the Heart Rhythm Society, one way to effectively combat this issue is the development of more AFib Centers of Excellence.

READ MORE >
Heart cardiologists doctors surgery
Share on Twitter Share on Facebook Share on Linkedin

Atrial Fibrillation Centers of Excellence: The best path forward for high-quality care and better outcomes

Share on Twitter Share on Facebook Share on Linkedin
Heart cardiologists doctors surgery
The world is in the throes of an AFib pandemic, one that could potentially get worse in the years ahead due to population growth, economic hardships and rigid resource limitations. According to the Heart Rhythm Society, one way to effectively combat this issue is the development of more AFib Centers of Excellence.
READ MORE >

SCAI pushes for better radiation protection in cath labs

Society of Cardiovascular Angiography and Interventions President James Hermiller, Jr., MD, explains SCAI's push for wider adoption of new, innovative cath lab radiation protection technology to reduce radiation exposure and the need for lead aprons.

READ MORE >
Society of Cardiovascular Angiography and Interventions (SCAI) President James B. Hermiller, Jr., MD, director of the transcatheter structural heart program at Ascension St. Vincent Heart Center in Indianapolis, explains SCAI's push for wider adoption of new, innovative cath lab radiation protection technology to reduce radiation exposure and the need for lead aprons that cause orthopedic injury.
Share on Twitter Share on Facebook Share on Linkedin

SCAI pushes for better radiation protection in cath labs

Share on Twitter Share on Facebook Share on Linkedin
Society of Cardiovascular Angiography and Interventions (SCAI) President James B. Hermiller, Jr., MD, director of the transcatheter structural heart program at Ascension St. Vincent Heart Center in Indianapolis, explains SCAI's push for wider adoption of new, innovative cath lab radiation protection technology to reduce radiation exposure and the need for lead aprons that cause orthopedic injury.
Society of Cardiovascular Angiography and Interventions President James Hermiller, Jr., MD, explains SCAI's push for wider adoption of new, innovative cath lab radiation protection technology to reduce radiation exposure and the need for lead aprons.
READ MORE >

FDA approves new AI-enabled wearable cardioverter defibrillator

The newly approved device can be worn for up to a week at a time, with no daily maintenance required, and includes advanced AI algorithms that minimize the risk of false alarms or inappropriate shocks.

READ MORE >
Jewel Patch Wearable Cardioverter Defibrillator from Element Science
Share on Twitter Share on Facebook Share on Linkedin

FDA approves new AI-enabled wearable cardioverter defibrillator

Share on Twitter Share on Facebook Share on Linkedin
Jewel Patch Wearable Cardioverter Defibrillator from Element Science
The newly approved device can be worn for up to a week at a time, with no daily maintenance required, and includes advanced AI algorithms that minimize the risk of false alarms or inappropriate shocks.
READ MORE >

Same-day discharge after cardiac ablation: Cardiologists share recommendations

Same-day discharge won't always be a great fit after cardiac ablation, of course, but it has been associated with considerable patient satisfaction as well as improved efficiency and substantial cost savings. The Heart Rhythm Society and American College of Cardiology have shared a new scientific statement on the subject. 

READ MORE >
doctor patient discharge after heart surgery
Share on Twitter Share on Facebook Share on Linkedin

Same-day discharge after cardiac ablation: Cardiologists share recommendations

Share on Twitter Share on Facebook Share on Linkedin
doctor patient discharge after heart surgery
Same-day discharge won't always be a great fit after cardiac ablation, of course, but it has been associated with considerable patient satisfaction as well as improved efficiency and substantial cost savings. The Heart Rhythm Society and American College of Cardiology have shared a new scientific statement on the subject. 
READ MORE >

FDA sees potential in new pacemaker-guided hypertension therapy

Orchestra BioMed and Medtronic have worked together on the new therapy, which is designed to work automatically without patients needing to take any additional steps.

READ MORE >
Orchestra BioMed Holdings AVIM Therapy FDA breakthrough device
Share on Twitter Share on Facebook Share on Linkedin

FDA sees potential in new pacemaker-guided hypertension therapy

Share on Twitter Share on Facebook Share on Linkedin
Orchestra BioMed Holdings AVIM Therapy FDA breakthrough device
Orchestra BioMed and Medtronic have worked together on the new therapy, which is designed to work automatically without patients needing to take any additional steps.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

FDA approves fast-acting heart drug for children | New safety data on LAAO | AI gets added value out of routine CT scans
Neurosurgeon treats stroke patient 120 miles away | Stereotaxis, Stryker make big moves | FDA's catheter warning | New AI for PE
Strokes after PFA | FDA links weight loss pill to cardiovascular risks | Stereotaxis to acquire Robocath | Antidepressants & SCD
Heartflow sues Cleerly | Outgoing SCAI president reflects on a busy year | FDA clears next-generation heart device
Heartflow sues AI rival Cleerly | Turning data into actionable insights | FDA clears new algorithms | Key innovations at ACC.26
FDA's warning for cath labs | Stryker to acquire IVL company | New data on resistant hypertension | More patients, fewer doctors
Fraud allegations lead to $4.75M settlement | Hospital sues cardiology practice | A new business model | Whoop raises $575M

Pagination

    • First page « First
    • Previous page ‹‹
    • Page …9
    • Page 10
    • Page 11
    • Page 12
    • Current page 13
    • Page 14
    • Page 15
    • Page 16
    • Page 17 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup